RecruitingNCT04616495
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases
Sponsor
Hospital Universitario La Fe
Enrollment
30 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Multicentric prospective and observational study to assess the 5-year overall survival in a cohort of patients with unresectable liver-only colorectal metastases, well controlled by chemotherapy prior to liver transplantation.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Plain Language Summary
Simplified for easier understanding
This study is exploring whether liver transplantation is a viable treatment option for carefully selected people with colorectal cancer that has spread only to the liver and cannot be surgically removed. Standard treatment does not include transplant for this condition, so this trial is testing a new approach.
**You may be eligible if...**
- You are 18 or older
- You had colorectal cancer that was completely removed (R0 resection) previously
- Your cancer has spread only to the liver and cannot be surgically removed
- Your liver metastases responded to 1–2 lines of chemotherapy
- You have been cancer-free elsewhere for at least 1 year before being listed for transplant
- You are in good health (ECOG 0 or 1)
**You may NOT be eligible if...**
- Your cancer has spread outside the liver
- Your tumor has a BRAF mutation
- You are HIV or Hepatitis C positive
- You are overweight (BMI ≥ 30) or have lost significant weight recently
- You are pregnant
- You have another active cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURELiver transplantation
Chemotherapy and liver transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04616495
Related Trials
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
NCT072011941 location
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT0591926433 locations
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
NCT06324357108 locations
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
NCT0605169512 locations
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
NCT055768968 locations